Your browser doesn't support javascript.
loading
HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability.
Kawazu, Masahito; Ueno, Toshihide; Saeki, Koichi; Sax, Nicolas; Togashi, Yosuke; Kanaseki, Takayuki; Chida, Keigo; Kishigami, Fumishi; Sato, Kazuhito; Kojima, Shinya; Otsuka, Masafumi; Kawazoe, Akihito; Nishinakamura, Hitomi; Yuka, Maeda; Yamamoto, Yoko; Yamashita, Kazuo; Inoue, Satoshi; Tanegashima, Tokiyoshi; Matsubara, Daisuke; Tane, Kenta; Tanaka, Yosuke; Iinuma, Hisae; Hashiguchi, Yojiro; Hazama, Shoichi; Khor, Seik-Soon; Tokunaga, Katsushi; Tsuboi, Masahiro; Niki, Toshiro; Eto, Masatoshi; Shitara, Kohei; Torigoe, Toshihiko; Ishihara, Soichiro; Aburatani, Hiroyuki; Haeno, Hiroshi; Nishikawa, Hiroyoshi; Mano, Hiroyuki.
Afiliación
  • Kawazu M; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan. Electronic address: mkawz-tky@umin.ac.jp.
  • Ueno T; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Saeki K; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Sax N; KOTAI Biotechnologies, Inc, Osaka Japan.
  • Togashi Y; Division of Cancer Immunology, Research Institute, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan.
  • Kanaseki T; Department of Pathology, School of Medicine, Sapporo Medical University, Sapporo, Japan.
  • Chida K; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Kishigami F; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan; Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan.
  • Sato K; Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan.
  • Kojima S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Otsuka M; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Kawazoe A; Division of Cancer Immunology, Research Institute, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Nishinakamura H; Division of Cancer Immunology, Research Institute, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan.
  • Yuka M; Division of Cancer Immunology, Research Institute, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan.
  • Yamamoto Y; Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan.
  • Yamashita K; KOTAI Biotechnologies, Inc, Osaka Japan.
  • Inoue S; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Tanegashima T; Division of Cancer Immunology, Research Institute, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Matsubara D; Division of Integrative Pathology, Jichi Medical University, Shimotsukeshi, Japan.
  • Tane K; Division of Cancer Immunology, Research Institute, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan; Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.
  • Tanaka Y; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
  • Iinuma H; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
  • Hashiguchi Y; Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan.
  • Hazama S; Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
  • Khor SS; Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Tokunaga K; Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Tsuboi M; Department of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan.
  • Niki T; Division of Integrative Pathology, Jichi Medical University, Shimotsukeshi, Japan.
  • Eto M; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Shitara K; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Torigoe T; Department of Pathology, School of Medicine, Sapporo Medical University, Sapporo, Japan.
  • Ishihara S; Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan.
  • Aburatani H; Genome Science Division, Research Center for Advanced Science and Technologies, The University of Tokyo, Tokyo, Japan.
  • Haeno H; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Nishikawa H; Division of Cancer Immunology, Research Institute, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Mano H; Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan; Research Institute, National Cancer Center Research Institute, Tokyo, Japan.
Gastroenterology ; 162(3): 799-812, 2022 03.
Article en En | MEDLINE | ID: mdl-34687740
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Genes MHC Clase I / Neoplasias Colorrectales / Microglobulina beta-2 / Escape del Tumor Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Gastroenterology Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Genes MHC Clase I / Neoplasias Colorrectales / Microglobulina beta-2 / Escape del Tumor Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Gastroenterology Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos